In Silico Elucidation of A Novel Peptide’s Inhibitory Mechanism Against KPC-2-Beta-Lactamase
Keywords:
Antimicrobial peptide, KPC-2-beta-lactamase, antibiotic resistance, in silico, molecular dockingAbstract
Antimicrobial resistance is a condition where antibiotics fail to treat pathogen-caused infections. Klebsiella pneumoniae carbapenemase-2 (KPC-2), a beta-lactamase enzyme produced by Klebsiella pneumoniae, is one of the five most harmful bacteria. It hydrolyzes strong antibiotics like imipenem and carbapenem. Antimicrobial peptides are naturally occurring compounds produced by numerous organisms. It can kill microbes due to their extensive antimicrobial action. This study aims to explain peptide 6B, which originated from frogs. The peptide sequence was modified to yield a 16-amino-acid peptide. In silico techniques were used to characterize the synthetic peptide and evaluate its inhibitory action against KPC-2.